LA JOLLA PHARMACEUTICAL CO Lease, Cost
LA JOLLA PHARMACEUTICAL CO reported Lease, Cost of $45.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-08-15
- LA JOLLA PHARMACEUTICAL CO lease, cost for the quarter ending 2022-06-30 was $45.00K, a 55.00% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO lease, cost for the quarter ending 2022-03-31 was $45.00K, a 55.00% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO lease, cost for the quarter ending 2021-12-31 was $100.00K, a 66.67% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO lease, cost for the quarter ending 2021-09-30 was $100.00K, a 85.71% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO lease, cost for fiscal 2021 was $300.00K, a 86.96% decline from fiscal 2020.
- LA JOLLA PHARMACEUTICAL CO lease, cost for fiscal 2020 was $2.30M, a 20.69% decline from fiscal 2019.
- LA JOLLA PHARMACEUTICAL CO lease, cost for fiscal 2019 was $2.90M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-06-30 | $45.00K 10-Q · filed 2022-08-15 | $100.00K 10-Q · filed 2022-08-15 | $190.00K derived: sum of 3 quarters · filed 2022-08-15 | $290.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | $45.00K 10-Q · filed 2022-05-16 | $145.00K derived: sum of 2 quarters · filed 2022-05-16 | $245.00K derived: sum of 3 quarters · filed 2022-05-16 | $345.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $200.00K derived: sum of 2 quarters · filed 2022-03-09 | $300.00K derived: sum of 3 quarters · filed 2022-08-15 | $300.00K 10-K · filed 2022-03-09 |
| 2021-09-30 | $100.00K 10-Q · filed 2021-11-04 | $200.00K derived: sum of 2 quarters · filed 2022-08-15 | $200.00K 10-Q · filed 2021-11-04 | $600.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-15 | $200.00K 10-Q · filed 2022-08-15 | $500.00K derived: sum of 3 quarters · filed 2022-08-15 | $1.20M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-16 | $400.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.10M derived: sum of 3 quarters · filed 2022-05-16 | $1.80M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $1.00M derived: sum of 2 quarters · filed 2022-03-09 | $1.70M derived: sum of 3 quarters · filed 2022-03-09 | $2.30M 10-K · filed 2022-03-09 |
| 2020-09-30 | $700.00K 10-Q · filed 2021-11-04 | $1.40M derived: sum of 2 quarters · filed 2021-11-04 | $2.00M 10-Q · filed 2021-11-04 | $2.90M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $700.00K 10-Q · filed 2021-08-05 | $1.40M 10-Q · filed 2021-08-05 | $2.20M derived: sum of 3 quarters · filed 2021-08-05 | $2.90M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $700.00K 10-Q · filed 2021-05-07 | $1.50M derived: sum of 2 quarters · filed 2021-05-07 | $2.20M derived: sum of 3 quarters · filed 2021-05-07 | $2.90M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $1.50M derived: sum of 2 quarters · filed 2021-03-08 | $2.20M derived: sum of 3 quarters · filed 2021-03-08 | $2.90M 10-K · filed 2021-03-08 |
| 2019-09-30 | $700.00K 10-Q · filed 2019-11-12 | $1.40M derived: sum of 2 quarters · filed 2020-08-06 | $2.10M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $700.00K 10-Q · filed 2020-08-06 | $1.40M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $700.00K 10-Q · filed 2020-05-04 | |||
| 2018-09-30 | $700.00K 10-Q · filed 2019-11-12 | $1.40M derived: sum of 2 quarters · filed 2019-11-12 | $2.10M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $700.00K 10-Q · filed 2019-08-01 | $1.40M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $700.00K 10-Q · filed 2019-05-06 |